title: Periprocedural management of new oral anticoagulants in patients undergoing atrial fibrillation ablation.
authors.affiliation: Departments of Medicine and Biochemistry, McMaster University, and Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada (J.I.W.); the Department of Medicine, McMaster University, and Population Health Research Institute, Hamilton, Ontario, Canada (J.S.H.); the Department of Medicine, Western University, London, Ontario, Canada (A.C.S.); and the Department of Medicine, University of Toronto, Toronto, Ontario, Canada (A.V.).
authors.forename: Jeffrey I
authors.initials: JI
authors.lastname: Weitz
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Healey
authors.forename: Allan C
authors.initials: AC
authors.lastname: Skanes
authors.forename: Atul
authors.initials: A
authors.lastname: Verma
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000175:diagnosis* / Q000628:therapy*; D017115:Catheter Ablation / Q000009:adverse effects; D019468:Disease Management; D005260:Female; D006801:Humans; D011300:Preoperative Care / Q000379:methods*; D014859:Warfarin / Q000008:administration & dosage
chemical_list: D000925:Anticoagulants; D014859:Warfarin